Cargando…
Explaining the difference in prognosis between screen-detected and symptomatic breast cancers
BACKGROUND: We analysed 10-year survival data in 19 411 women aged 50–64 years diagnosed with invasive breast cancer in the West Midlands region of the United Kingdom. The aim was to estimate the survival advantage seen in cases that were screen detected compared with those diagnosed symptomatically...
Autores principales: | Allgood, P C, Duffy, S W, Kearins, O, O'Sullivan, E, Tappenden, N, Wallis, M G, Lawrence, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111158/ https://www.ncbi.nlm.nih.gov/pubmed/21540862 http://dx.doi.org/10.1038/bjc.2011.144 |
Ejemplares similares
-
Breast screening histories: variation with time and impact on 10-year survival
por: Tappenden, N, et al.
Publicado: (2006) -
Clinical outcome data for symptomatic breast cancer: the breast cancer clinical outcome measures (BCCOM) project
por: Bates, T, et al.
Publicado: (2009) -
The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
por: Wallis, M G, et al.
Publicado: (2012) -
Effects of specialisation on treatment and outcomes in screen-detected breast cancers in Wales: cohort study
por: Allgood, P C, et al.
Publicado: (2006) -
Pathology quality assurance: the use of control charts
por: O'Sullivan, E, et al.
Publicado: (2006)